Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Alzheimer's Disease

Free Subscription 06.07.2026 1 Acta Neuropathol 11 Alzheimers Dement 3 BMC Geriatr 1 BMC Neurol 4 Curr Alzheimer Res 1 Exp Gerontol 1 Exp Neurol 13 J Alzheimers Dis 1 J Neurochem 2 J Neurol 1 JAMA 1 Nat Med 1 Nat Neurosci 1 Neurobiol Aging 1 Neurobiol Dis 2 Neurochem Res 4 Neurology 1 PLoS Genet

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. DI BARI MA, Bruno R, Riccardi G, Vanni I, et al
   Prion-like transmission and propagation of human beta-amyloid to the bank vole rodent model.
   Acta Neuropathol. 2026;151:75.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

2. PRADOS M, Acosta C, Mattke S
   Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.
   Alzheimers Dement. 2026;22:e71628.
   PubMed         Abstract available
   
   
3. CERON C, Casquero-Veiga M, Lamanna-Rama N, Fernandez-Nueda I, et al
   Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.
   Alzheimers Dement. 2026;22:e71652.
   PubMed         Abstract available
   
   
4. HAZAN J, Liu KY, Howard R
   What should convince a clinician of disease modification in Alzheimer's disease clinical trials?
   Alzheimers Dement. 2026;22:e71643.
   PubMed         Abstract available
   
   
5. GULERIA VS, Winston CN
   Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.
   Alzheimers Dement. 2026;22:e71645.
   PubMed         Abstract available
   
   
6. PANTELEIENKO L, Banerjee G, Mallon D, Chan E, et al
   Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.
   Alzheimers Dement. 2026;22:e71640.
   PubMed         Abstract available
   
   
7. LI Y, Wang D, Zhou R, Yan S, et al
   Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71638.
   PubMed         Abstract available
   
   
8. CARY GA, Young JE, Rose SE, Frankowski H, et al
   Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71562.
   PubMed         Abstract available
   
   
9. LEE J, Olafson E, Toth B, Casavant E, et al
   Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71604.
   PubMed         Abstract available
   
   
10. BIRDITT KR, Mavromati K, Swann P, Quinn T, et al
    Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.
    Alzheimers Dement. 2026;22:e71642.
    PubMed         Abstract available
    
    
11. JAVONILLO DI, Furman S, Le L, Fernandez K, et al
    Acute viral encephalitis impacts dense-core amyloid plaque pathology and dysregulates myeloid responses to amyloid plaques.
    Alzheimers Dement. 2026;22:e71637.
    PubMed         Abstract available
    
    
12. PREITNER N, Dehlinger V, Rodriguez P, Fabbri K, et al
    Elimination of tau tangles and soluble aggregates with the small molecule ACI-16664 prevents neurodegeneration in vivo.
    Alzheimers Dement. 2026;22:e71572.
    PubMed         Abstract available
    
    

    
    BMC Geriatr

13. KWON J, Chang MK, Gordon-Boyle A, Creavin S, et al
    Blood biomarkers to improve dementia diagnostic accuracy: a cross-sectional analysis.
    BMC Geriatr. 2026;26:888.
    PubMed         Abstract available
    
    
14. TANG Y, Yang R, Zhang M, Zhou C, et al
    Classifying drug-related problems of neurodegenerative diseases in the physician-pharmacist joint clinic of neurology: an application of the PCNE method.
    BMC Geriatr. 2026;26:475.
    PubMed         Abstract available
    
    
15. TURNER SG, Brody L, Mei L, Figueroa-Nieves A, et al
    The pain identification and communication toolkit: a training program to support family caregivers of persons with ADRD.
    BMC Geriatr. 2025 Dec 4. doi: 10.1186/s12877-025-06717.
    PubMed        
    
    

    
    BMC Neurol

16. VIDYANTI AN, Rahmadini A, Rahman RH, Prodjohardjono A, et al
    Secondary narcolepsy and cognitive dysfunction related to craniopharyngioma: a case study.
    BMC Neurol. 2026 Jan 15. doi: 10.1186/s12883-026-04629.
    PubMed        
    
    

    
    Curr Alzheimer Res

17. XING Z, Jiang X, Yang W, Wang Y, et al
    Corrigendum to: Lithium Chloride Improves Electrophysiological and Memory Deficits in Rats with Streptozotocin-Induced Alzheimer's Disease.
    Curr Alzheimer Res. 2026;23:75.
    PubMed         Abstract available
    
    
18. BOUDI A, He J, El Kader IA, Liu X, et al
    Corrigendum to: Advancing Alzheimer's Disease Diagnosis Using VGG19 and XGBoost: A Neuroimaging-Based Method.
    Curr Alzheimer Res. 2026;23:76.
    PubMed         Abstract available
    
    
19. LI Y, Xie K, Qian S, Wang Z, et al
    Quantifying Short-Term Functional Changes After Lecanemab Treatment in Early Alzheimer's Disease: An Exploratory 3-Month Follow-Up Case Report Using Eye Movement and Gait Analysis.
    Curr Alzheimer Res. 2026 Jun 29. doi: 10.2174/0115672050471024260520113701.
    PubMed         Abstract available
    
    
20. MEHRABADI S
    The Role of Digital Health Technologies in Early Detection and Management of Alzheimer's Disease.
    Curr Alzheimer Res. 2026 Jun 29. doi: 10.2174/0115672050415800251226061142.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

21. QIU X, Liu Z, Wang L, Yuan Y, et al
    Time-dependent circulating metabolic changes and key regulatory pathways in Alzheimer's disease: A combined animal model and public database study.
    Exp Gerontol. 2026;222:113216.
    PubMed         Abstract available
    
    

    
    Exp Neurol

22. QUACH B, Salehi S, Roufegarinejad R, Guleria VS, et al
    Neuropathological and functional impact of astrocyte-derived extracellular vesicles in an aged model of Alzheimer's disease.
    Exp Neurol. 2026 Jul 3:115893. doi: 10.1016/j.expneurol.2026.115893.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

23. ZHU Y, Trani JF, Walker AIB, Bekena S, et al
    Differential associations of core and non-core plasma biomarkers with cognitive performance in Black adults.
    J Alzheimers Dis. 2026;112:380-388.
    PubMed         Abstract available
    
    
24. SOZIO SJ, Sahai A, Khalafi M, Wang X, et al
    Poor R-wave progression associates with cerebral amyloid deposition: A potential link between heart and brain.
    J Alzheimers Dis. 2026;112:188-197.
    PubMed         Abstract available
    
    
25. KAWABE N, Hosoki S, Watanabe C, Maekawa K, et al
    Logical memory is associated with amyloid-beta positivity in patients with early Alzheimer's disease eligible for lecanemab.
    J Alzheimers Dis. 2026 Jun 27:13872877261462928. doi: 10.1177/13872877261462928.
    PubMed         Abstract available
    
    
26. SHAW JS, Bray MJC, Sair HI, Luna LP, et al
    Relationship between new-onset falls and neuroimaging markers of Alzheimer's disease in the UK Biobank.
    J Alzheimers Dis. 2026 Jun 27:13872877261462930. doi: 10.1177/13872877261462930.
    PubMed         Abstract available
    
    
27. SATO K, Niimi Y, Ihara R, Suzuki K, et al
    Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapies.
    J Alzheimers Dis. 2026 Jun 27:13872877261464182. doi: 10.1177/13872877261464182.
    PubMed         Abstract available
    
    
28. 
    Corrigendum to "Electromagnetic field induced activation of amyloid-beta degrading enzyme, neprilysin, for accelerated Alzheimer's disease therapy".
    J Alzheimers Dis. 2026 Jun 28:13872877261463830. doi: 10.1177/13872877261463830.
    PubMed        
    
    
29. CANTONI V, Grassi M, Premi E, Cupidi C, et al
    Long-term effects of multisession gamma transcranial alternating current stimulation in Alzheimer's disease.
    J Alzheimers Dis. 2026 Jun 30:13872877261461248. doi: 10.1177/13872877261461248.
    PubMed         Abstract available
    
    
30. CHUNG MLK, Takeda S, Ryu J, Murayama S, et al
    Carboxy terminal of ECRG4 is a potential initiator for amyloid pathology in Alzheimer's disease through interacting with APP intracellular domain.
    J Alzheimers Dis. 2026 Jun 30:13872877261462890. doi: 10.1177/13872877261462890.
    PubMed         Abstract available
    
    
31. RASHID MI, Abbas M, Tahir R, Alam T, et al
    National trends and disparities in mortality among U.S. older adults, with coexisting Alzheimer's disease and hypertension, 1999-2023.
    J Alzheimers Dis. 2026 Jun 30:13872877261461304. doi: 10.1177/13872877261461304.
    PubMed         Abstract available
    
    
32. CHEN PY, Shieh WY, Weng LC, Tsai HH, et al
    Process-level eye-movement dynamics enhance sensitivity to early Alzheimer's disease-related cognitive vulnerability.
    J Alzheimers Dis. 2026 Jun 30:13872877261457344. doi: 10.1177/13872877261457344.
    PubMed         Abstract available
    
    
33. ABEDIN MJ, Lee YF, Zhang M, Russ AN, et al
    Compartment-specific analysis reveals disrupted astrocytic calcium transients in anesthetized Alzheimer's disease mice.
    J Alzheimers Dis. 2026 Jun 30:13872877261464208. doi: 10.1177/13872877261464208.
    PubMed         Abstract available
    
    
34. KPETOU R, Raposo Pereira F, Segobin S, La Corte V, et al
    Multilayer brain connectivity and long-term cognitive changes in individuals at risk for Alzheimer's disease.
    J Alzheimers Dis. 2026 Jul 1:13872877261464453. doi: 10.1177/13872877261464453.
    PubMed         Abstract available
    
    
35. LIU Y, Wang X, Huang W, Li R, et al
    Gut microbiota alterations in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
    J Alzheimers Dis. 2026 Jul 2:13872877261465913. doi: 10.1177/13872877261465913.
    PubMed         Abstract available
    
    

    
    J Neurochem

36. SOUSA RAL, Costa JMM, Pereira RRS, Vieira LCDR, et al
    Exercise Snacking in Alzheimer's Disease: A Mechanistic Rationale Based on Repeated Exerkine Signaling.
    J Neurochem. 2026;170:e70517.
    PubMed        
    
    

    
    J Neurol

37. PETERSEN CE, Damsgaard L, Janbek J, Laursen TM, et al
    Morbidity and medication use preceding a diagnosis of late-onset Alzheimer's disease: a Danish nationwide study.
    J Neurol. 2026;273:443.
    PubMed         Abstract available
    
    
38. SPALLAZZI M, Zilioli A, Ruffini L, Imbimbo BP, et al
    Number needed to treat and harm for lecanemab and donanemab in early Alzheimer disease.
    J Neurol. 2026;273:436.
    PubMed        
    
    

    
    JAMA

39. RUBIN R
    First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds.
    JAMA. 2026 Jul 2. doi: 10.1001/jama.2026.12326.
    PubMed        
    
    

    
    Nat Med

40. PHILLIPS B, Sanford J, Janve VA, Liu M, et al
    Blood-based circular RNAs for early diagnosis of Alzheimer's disease.
    Nat Med. 2026 Jul 1. doi: 10.1038/s41591-026-04485.
    PubMed         Abstract available
    
    

    
    Nat Neurosci

41. ZHOU Y, Li WL, Liu ZQ, Ai WQ, et al
    Author Correction: Spinal cord Tau pathology induces tactile deficits and cognitive impairment in Alzheimer's disease via dysregulation of CCK neurons.
    Nat Neurosci. 2026 Jul 1. doi: 10.1038/s41593-026-02356.
    PubMed        
    
    

    
    Neurobiol Aging

42. SERRA L, Mancini M, Bonarota S, Caruso G, et al
    Hippocampal-cortical structural networks in the progression of cognitive impairment: A source-based morphometry analysis in individuals with subjective cognitive decline, mild cognitive impairment and Alzheimer's disease.
    Neurobiol Aging. 2026;167:129-145.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

43. KITAGAWA T, Kamagata K, Uchida W, Takabayashi K, et al
    Investigating tau-related white matter degeneration in Alzheimer's disease using fixel-based analysis.
    Neurobiol Dis. 2026 Jul 1:107518. doi: 10.1016/j.nbd.2026.107518.
    PubMed         Abstract available
    
    

    
    Neurochem Res

44. JADHAV VP, Mohanty PK
    Neuroprotective Effects of Citropten Against Scopolamine-Induced Cognitive Impairment and Oxidative Stress in a Rat Model.
    Neurochem Res. 2026;51:89.
    PubMed         Abstract available
    
    
45. DU M, Ma S, Bai L, Mou X, et al
    Olfactory Dysfunction Exacerbates Hippocampal Abeta Accumulation, Tau Phosphorylation and Memory Deficits in Mice.
    Neurochem Res. 2026;51:131.
    PubMed         Abstract available
    
    

    
    Neurology

46. LICHTER DG
    Neuropathogenesis of Seizures in Patients With Alzheimer Disease and Lewy Body Dementia: Is There a Difference, and Does It Matter?
    Neurology. 2026;107:e218344.
    PubMed        
    
    
47. TORT-MERINO A, Esteller-Gauxax D, Perez-Millan A, Castellvi M, et al
    Neuropsychological Profile and Cognitive Trajectories of Patients With Biomarker Evidence of Alzheimer Disease or Dementia With Lewy bodies.
    Neurology. 2026;107:e218201.
    PubMed         Abstract available
    
    
48. TING SKS, Saffari SE, Zhan SJ, Gosavi TD, et al
    Neuropathologic Correlates of Seizures in Patients With Alzheimer Disease and Dementia With Lewy Bodies.
    Neurology. 2026;107:e218277.
    PubMed         Abstract available
    
    
49. MORRILL VN, Pike JR, Hu J, Fornage M, et al
    Genetic Risk for Alzheimer Disease, Midlife Hypertension, and Dementia: The ARIC Neurocognitive Study.
    Neurology. 2026;107:e218280.
    PubMed         Abstract available
    
    

    
    PLoS Genet

50. CHOLERTON B, Godrich D, Pasteris J, Rivero J, et al
    Genome wide association study meta-analysis of neuropathologic lesions of Alzheimer's disease and related dementias in a multi-site autopsy cohort.
    PLoS Genet. 2026;22:e1012170.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum